Stay updated with breaking news from Core Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Minneapolis Heart Institute Foundation® (MHIF) today announced an important research milestone with the U.S. Food and Drug Administration (FDA) approval of the TriClip™ (manufactured by Abbott), a first-of-its-kind, non-surgical, transcatheter
Abbott has announced U.S Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 million people in the U.S. are estimated to be affected. Data from the TRILUMINATE Pivotal trial demonstrated that patients who received TriClip experienced a marked improvement in the severity of their symptoms and quality of life, with benefits sustained at one year.
Greenland ice sheet holds North America's environmental history clues despite distance.
Core Laboratories N.V. (NYSE:CLB) Q4 2023 Earnings Call Transcript February 1, 2024 Core Laboratories N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the Core Laboratories Fourth Quarter 2023 Earnings Conference Call. All participants will […]
CLB earnings call for the period ending December 31, 2023.